Gangyu Zhang
Guangzhou, 510405, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation" [Pharmacol. Res. 159 (2020) 104944].
Journal: Pharmacological research
Published: October 24, 2024
Loganin inhibits the ROS-NLRP3-IL-1β axis by activating the NRF2/HO-1 pathway against osteoarthritis.
Journal: Chinese journal of natural medicines
Published: January 06, 2024
Study on the potential active components and molecular mechanism of Xiao Huoluo Pills in the treatment of cartilage degeneration of knee osteoarthritis based on bioinformatics analysis and molecular docking technology.
Journal: Journal of orthopaedic surgery and research
Published: May 07, 2021
12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation.
Journal: International immunopharmacology
Published: May 03, 2021
Mechanosensitive Piezo1 in endothelial cells promotes angiogenesis to support bone fracture repair.
Journal: Cell calcium
Published: April 13, 2021
Up-regulation of urinary exosomal hsa-microRNA-200b-3p and hsa-microRNA-206 in patients of steroid-induced osteonecrosis of femoral head.
Journal: American journal of translational research
Published: January 23, 2021
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
Journal: Pharmacological research
Published: March 26, 2020
Serum exosomal hsa-miR-135b-5p serves as a potential diagnostic biomarker in steroid-induced osteonecrosis of femoral head.
Journal: American journal of translational research
Published: February 18, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026